Blood 116 , 43384348 (2010)
However, less than 9% of individuals had either a diabetes or prediabetes diagnosis within 90 days after starting a GLP-1 RA across the study years ( DISCUSSION GLP-1 RA prescribing increased significantly across the study years, especially for semaglutides, whereas dulaglutide, liraglutide, and exenatide decreased their share among GLP-1 RA users
STAT News reported last month that Astra Zeneca agreed to provide the Medicaid program with discounted drug prices, supposedly in line with what it offers other comparably wealthy countries
As noted, a phase 2 trial of retatrutide reported about 24% average body weight reduction in 48 weeks on the highest dose
This is typically 4060% less than Wegovy's out-of-pocket cost, and your price stays flat regardless of dose increases
Thats a car payment, Al-Aly says